Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription

Journal of Virology

Volumn 79, Issue 11, 2005, Pages 6610-6619

  Lewinski, M K ^a   Bisgrove, D ^c   Shinn, P ^a   Chen, H ^a   Hoffmann, C ^b   Hannenhalli, S ^b   Verdin, E ^c   Berry, C C ^d   Ecker, J R ^a   Bushman, F D ^a,b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ARTICLE; CELL POPULATION; CELL SEPARATION; CHROMOSOMAL LOCALIZATION; CHROMOSOME POSITIONING; GENE EXPRESSION; GENOME ANALYSIS; HETEROCHROMATIN; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROVIRUS; VIRUS GENOME; VIRUS TRANSCRIPTION;

BASE SEQUENCE; CHROMOSOMES, HUMAN; DNA; DNA, VIRAL; GENE SILENCING; GENES, REGULATOR; GENES, VIRAL; GENOME, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROVIRUSES; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 21044451712     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.11.6610-6619.2005     Document Type: Article

References (50)

1. Blankson, J. N., D. Persaud, and R. F. Siliciano. 2002. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:557-593.
2. Bor, Y.-C., M. Miller, F. Bushman, and L. Orgel. 1996. Target sequence preferences of HIV-1 integration complexes in vitro. Virology 222:238-242.
3. Boyle, S., S. Gilchrist, J. M. Bridger, N. L. Mahy, J. A. Ellis, and W. A. Bickmore. 2001. The spatial organization of human chromosomes within the nuclei of normal and emerin-mutant cells. Hum. Mol. Genet. 10:211-219.
4. Callen, B. P., K. E. Shearwin, and J. B. Egan. 2004. Transcriptional interference between convergent promoters caused by elongation over the promoter. Mol. Cell 14:647-656.
5. Carteau, S., C. Hoffmann, and F. D. Bushman. 1998. Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target. J. Virol. 72:4005-4014.
6. Casolari, J. M., C. R. Brown, S. Komili, J. West, H. Hieronymus, and P. A. Silver. 2004. Genome-wide localization of the nuclear transport machinery couples transcriptional status and nuclear organization. Cell 117:427-439.
7. Castillio-Davis, C. I., S. L. Mekhedov, D. L. Hartl, E. Koonin, and F. A. Kondrashov. 2002. Selection for short introns in highly expressed genes. Nat. Genet. 31:415-418.
8. Chubb, J. R., and W. A. Bickmore. 2003. Considering nuclear compartmentalization in light of nuclear dynamics. Cell 112:403-406.
9. Chun, T.-W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. M. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193-13197.
10. Cullen, B. R., P. T. Lomedico, and G. Ju. 1984. Transcriptional interference in avian retroviruses - implications for the promoter insertion model of leukaemogenesis. Nature 307:241-245.
11. de la Fuente, C., F. Santiago, L. Deng, C. Eadie, I. Zilberman, K. Kehn, A. Maddukuri, S. Baylor, K. Wu, C. G. Lee, A. Pumfery, and F. Kashanchi. 2002. Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem. 3:14.
12. Emerman, M., and M. H. Malim. 1998. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280:1880-1884.
13. Fields, B. N., and D. M. Kinpe. 1996. Virology. Raven Press, New York, N.Y.
14. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
15. Freed, E. O. 2004. HIV-1 and the host cell: an intimate association. Trends Microbiol. 12:170-177.
16. Friddle, C. J., et al. 2003. High-throughput mouse knockouts provide a functional analysis of the genome. Cold Spring Harbor Symp. Quant. Biol. 68:311-315.
17. + T lymphocytes. J. Immunol. 159:5993-5999.
18. Garber, M., and K. A. Jones. 1999. HIV-1 Tat: coping with negative elongation factors. Curr. Opin. Immunol. 11:460-465.
19. Greger, I. H., A. Aranda, and N. J. Proudfoot. 2000. Balancing transcriptional interference and initiation on the GAL7 promoter of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 97:8415-8420.
20. Greger, I. H., F. Demarchi, M. Giacca, and N. J. Proudfoot. 1998. Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter. Nucleic Acids Res. 26:1294-1301.
21. + T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol. 78:6122-6133.
22. Hausler, B., and R. L. Somerville. 1979. Interaction in vivo between strong closely spaced constitutive promoters. J. Mol. Biol. 127:353-356.
23. Hu, W. Y., F. D. Bushman, and A. C. Siva. 2004. RNA interference against retroviruses. Virus Res. 102:59-64.
24. Izmailova, E., F. M. Bertley, Q. Huang, N. Makori, C. J. Miller, R. A. Young, and A. Aldovini. 2003. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat. Med. 9:191-197.
25. Jenuwein, T. 2001. Re-SET-ting heterochromatin by histone methyltransferases. Trends Cell Biol. 11:266-273.
26. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293:1074-1080.
27. Jordan, A., D. Bisgrove, and E. Verdin. 2003. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22:1868-1877.
28. Jordan, A., P. Defechereux, and E. Verdin. 2001. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20:1726-1738.
29. Kanarawa, S., T. Okamoto, and B. M. Peterlin. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12:61-70.
30. Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489-493.
31. Lukacsovich, T., and D. Yamomoto. 2001. Trap a gene and find out its function: toward functional genomics in Drosophila. J. Neurogenet. 15:147-168.
32. Manger, B., A. Weiss, K. J. Hardy, and J. D. Stobo. 1986. A transferrin receptor antibody represents one signal for the induction of IL 2 production by a human T cell line. J. Immunol. 136:532-538.
33. Martens, J. A., L. Laprade, and F. Winston. 2004. Intergenic transcription is required to repress the Saccharomyes cerevisiae SER3 gene. Nature 429:571-574.
34. Mitchell, R., B. Beitzel, A. Schroder, P. Shinn, H. Chen, C. Berry, J. R. Ecker, and F. D. Bushman. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2:E234.
35. Morris, K. V., S. W. Chan, S. E. Jacobsen, and D. J. Looney. 2004. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305:1289-1292.
36. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
37. Plasterk, R. H. 2002. RNA silencing: the genome's immune system. Science 296:1263-1265.
38. Scherer, L. J., and J. J. Rossi. 2003. Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21:1457-1465.
39. Schmid, R. M., N. D. Perkins, C. S. Duckett, P. C. Andrews, and G. J. Nabel. 1991. Cloning of an NF-kappa-B subunit which stimulates HIV transcription in synergy with p65. Nature 352:733-736.
40. Schroder, A., P. Shinn, H. Chen, C. Berry, J. R. Ecker, and F. D. Bushman. 2002. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521-529.
41. She, X., J. E. Horvath, Z. Jiang, G. Liu, T. S. Furey, L. Christ, R. Clark, T. Graves, C. L. Gulden, C. Alkan, J. A. Bailey, C. Sahinalp, M. Rocchi, D. Haussler, R. K. Wilson, W. Miller, S. Schwartz, and E. E. Eichler. 2004. The structure and evolution of centromeric transition regions within the human genome. Nature 430:857-864.
42. Sheridan, P. L., T. P. Mayall, E. Verdin, and K. A. Jones. 1997. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev. 24:3327-3340.
43. Stevens, S. W., and J. D. Griffith. 1996. Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration. J. Virol. 70:6459-6462.
44. Su, A. I., T. Wiltshire, S. Batalov, H. Lapp, K. A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, G. Kreiman, M. P. Cooke, J. R. Walker, and J. B. Hogenesch. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101:6062-6067.
45. Verdin, E. 1991. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J. Virol. 65:6790-6799.
46. Wallrath, L. L. 1998. Unfolding the mysteries of heterochromatin. Curr. Opin. Genet. Dev. 8:147-153.
47. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
48. Wolffe, A. P. 1998. Chromatin, 3rd ed. Academic Press, San Diego, Calif.
49. Wong, J. K., M. Hezareh, H. F. Gunthard, D. V. Havlir, C. C. Ignacio, C. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged supression of plasma viremia. Science 278:1291-1295.
50. Wu, X., Y. Li, B. Crise, and S. M. Burgess. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751.